INZY
Inozyme Pharma, Inc.
Director Robert Lorne Hopfner bought $2.8M of Inozyme Pharma, Inc.
Bought$2,849,998
$6.36Price
447,932Shares
+14%Stake
What INZY did for a copier
- $1,000 copied at Mon, May 15 close, $6.49
- $875
- S&P 500, same days
- +6.1%
Measured over 30 trading days, to the Jun 28 close.
Robert Lorne Hopfner's record
3 other buys with 3 months of prices since 2021: on average −14.3% against the S&P 500, and 1 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 11. Filed Mon, May 15, 1:06 PM ET, during the session. Returns use the May 15 close and the Jun 28 close. Not investment advice.